These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 28891089)

  • 1. Molecular insights into the transcriptional regulatory role of thyroid hormones in ovarian cancer.
    Shinderman-Maman E; Weingarten C; Moskovich D; Werner H; Hercbergs A; Davis PJ; Ellis M; Ashur-Fabian O
    Mol Carcinog; 2018 Jan; 57(1):97-105. PubMed ID: 28891089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The thyroid hormone-αvβ3 integrin axis in ovarian cancer: regulation of gene transcription and MAPK-dependent proliferation.
    Shinderman-Maman E; Cohen K; Weingarten C; Nabriski D; Twito O; Baraf L; Hercbergs A; Davis PJ; Werner H; Ellis M; Ashur-Fabian O
    Oncogene; 2016 Apr; 35(15):1977-87. PubMed ID: 26165836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Interplay Between Epithelial-Mesenchymal Transition (EMT) and the Thyroid Hormones-αvβ3 Axis in Ovarian Cancer.
    Weingarten C; Jenudi Y; Tshuva RY; Moskovich D; Alfandari A; Hercbergs A; Davis PJ; Ellis M; Ashur-Fabian O
    Horm Cancer; 2018 Feb; 9(1):22-32. PubMed ID: 29260382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear monomeric integrin αv in cancer cells is a coactivator regulated by thyroid hormone.
    Lin HY; Su YF; Hsieh MT; Lin S; Meng R; London D; Lin C; Tang HY; Hwang J; Davis FB; Mousa SA; Davis PJ
    FASEB J; 2013 Aug; 27(8):3209-16. PubMed ID: 23640055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered response to thyroid hormones by breast and ovarian cancer cells.
    Martinez MB; Ruan M; Fitzpatrick LA
    Anticancer Res; 2000; 20(6B):4141-6. PubMed ID: 11205239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of the thyroid hormones-αvβ3 pathway in primary myeloma bone marrow cells and to bortezomib action.
    Cohen K; Ellis M; Shinderman E; Khoury S; Davis PJ; Hercbergs A; Ashur-Fabian O
    Leuk Lymphoma; 2015 Apr; 56(4):1107-14. PubMed ID: 25058375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptotic effects of salinomycin on human ovarian cancer cell line (OVCAR-3).
    Kaplan F; Teksen F
    Tumour Biol; 2016 Mar; 37(3):3897-903. PubMed ID: 26476539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly.
    Zhang X; Huang L; Zhao Y; Tan W
    Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):995-1001. PubMed ID: 24145606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of apoptosis in human ovarian epithelial cancer cells by antisurvivin oligonucleotides.
    Ma X; Wang S; Zhou J; Xing H; Xu G; Wang B; Chen G; Lu YP; Ma D
    Oncol Rep; 2005 Jul; 14(1):275-9. PubMed ID: 15944801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of histone deacetylase inhibitors on cell apoptosis and expression of the tumor suppressor genes RUNX3 and ARHI in ovarian tumors.
    Zhang L; Liu P; Li H; Xue F
    Mol Med Rep; 2013 May; 7(5):1705-9. PubMed ID: 23504001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy for human ovarian cancer cells using efficient expression of Fas gene combined with γδT cells.
    Lin J; Zeng D; He H; Tan G; Lan Y; Jiang F; Sheng S
    Mol Med Rep; 2017 Oct; 16(4):3791-3798. PubMed ID: 28765933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid hormones (T3 and T4): dual effect on human cancer cell proliferation.
    Moriggi G; Verga Falzacappa C; Mangialardo C; Michienzi S; Stigliano A; Brunetti E; Toscano V; Misiti S
    Anticancer Res; 2011 Jan; 31(1):89-96. PubMed ID: 21273585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid hormone-mediated regulation of lipocalin 2 through the Met/FAK pathway in liver cancer.
    Chung IH; Chen CY; Lin YH; Chi HC; Huang YH; Tai PJ; Liao CJ; Tsai CY; Lin SL; Wu MH; Chen CY; Lin KH
    Oncotarget; 2015 Jun; 6(17):15050-64. PubMed ID: 25940797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-HPR modulates gene expression in ovarian cells.
    Brewer M; Kirkpatrick ND; Wharton JT; Wang J; Hatch K; Auersperg N; Utzinger U; Gershenson D; Bast R; Zou C
    Int J Cancer; 2006 Sep; 119(5):1005-13. PubMed ID: 16570282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of gene expression identifies PLAB as a mediator of the apoptotic activity of fenretinide in human ovarian cancer cells.
    Appierto V; Villani MG; Cavadini E; Gariboldi M; De Cecco L; Pierotti MA; Lambert JR; Reid J; Tiberio P; Colombo N; Formelli F
    Oncogene; 2007 Jun; 26(27):3952-62. PubMed ID: 17213814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific inhibition of AKT2 by RNA interference results in reduction of ovarian cancer cell proliferation: increased expression of AKT in advanced ovarian cancer.
    Noske A; Kaszubiak A; Weichert W; Sers C; Niesporek S; Koch I; Schaefer B; Sehouli J; Dietel M; Lage H; Denkert C
    Cancer Lett; 2007 Feb; 246(1-2):190-200. PubMed ID: 16584837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid hormones directly interact with vascular smooth muscle strips.
    Ishikawa T; Chijiwa T; Hagiwara M; Mamiya S; Hidaka H
    Mol Pharmacol; 1989 Jun; 35(6):760-5. PubMed ID: 2733694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma.
    Ma JJ; Chen BL; Xin XY
    Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):222-6. PubMed ID: 19758744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of type II L-thyroxine, 5'-monodeiodinase in cultured GC cells: different pathways of regulation by L-triiodothyronine and 3,3',5'-triiodo-L-thyronine.
    Halperin Y; Shapiro LE; Surks MI
    Endocrinology; 1994 Oct; 135(4):1464-9. PubMed ID: 7925108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luteinizing hormone-releasing hormone agonist triptorelin and antagonist cetrorelix inhibit EGF-induced c-fos expression in human gynecological cancers.
    Gründker C; Völker P; Schulz KD; Emons G
    Gynecol Oncol; 2000 Aug; 78(2):194-202. PubMed ID: 10926802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.